{"id": "1356778194058301442", "creation": 1612316103.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 4, "quote_count": 0}}, "text": ".@DynavaxCorp Promising Future Pops Stock in a 60%-Plus Rally: Analyst Weighs In\n\nUK government deal for Valneva\u2019s #Covid19 #vaccine VLA2001 that utilizes CpG 1018 could bring $DVAX up to $230 million in 2021 revenues. \n\n$ARCT $ATRA $VBIV $VXRT #stocks\n\nhttps://t.co/ixvFS7agjK", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#STOCKS"]}